7th Treg-Directed Therapies Summit

Date : 25th March 2025 to 27th March 2025

Place : United States of America, Boston

Website :http://go.evvnt.com/2753136-2?pid=80

Contact Person:Clarice Handley

Description:

Unravelling Treg Biology, Pioneering Best-in-Class Approaches and Demonstrating Clinical Efficacy to Advance Validated Therapeutic Options in Autoimmunity, Inflammation and Beyond. Time: 8:00 AM - 5:00 PM. Prices: USD 2599.00 - USD 5097.00.

7th Treg-Directed Therapies Summit will be held in Boston,United States of America on date 2025-03-27

---

Deadline for abstracts/proposals : 25th March 2025

Keynote Speakers :

Conference Highlights :Home | 7th Treg Directed Therapies Summit
The 7th Treg-Directed Therapies Summit is returning to Boston, driving next gen Treg stimulation for autoimmunity, transplantation, and inflammation.

Over the past year, the Treg sector has seen groundbreaking investments and strategic collaborations between leading biotech and pharma companies likeQuellandAstraZeneca, andParvusandAbbVie, creating a surge of innovation and spotlighting Treg cell therapies and modulators as the next frontier in autoimmune and inflammatory disease treatments. Tregs hold the potential to revolutionize care for conditions that have long lacked effective solutions and are the future of precision medicine in autoimmune and inflammatory diseases.
Welcome to the7thTreg-Directed Therapies Summit, the premier event dedicated to exploring and overcoming the unique challenges and advancements specific to Treg. Offering you exclusive access to the latest industry insights, clinical data, Treg biology breakthroughs and strategies for advancing therapies to the clinic from trailblazing companies and academic leaders, includingAbata Therapeutics,Harvard Medical School,Nektar Therapeutics,Parvus Therapeutics,PolTreg,ThyTechand many more!
Whether you are in discovery, navigating the complexities of IND filings, or transitioning to the clinic, this forum provides an unparalleled opportunity to engage with companies and academics at the forefront of cell therapy and modulator innovation. Connect with senior experts in cell therapy manufacturing and modulator production, build strategic relationships with investors, pharmaceutical companies and academics, opening doors to future collaborations and partnership opportunities. Featuring two tracks - one focused on Treg Cell Therapies and the other on Treg Modulators - this summit offers a unique opportunity to gain knowledge from the latest engineering innovations and clinical advancements.
Chief Scientific Officer
Intellia Therapeutics

Check the event website for more details.